New onset autoimmune diabetes mellitus and hypothyroidism secondary to pembrolizumab in a patient with metastatic lung cancer

SUMMARY: Immunotherapy has become an important pillar for the management of advanced cancer. Immune-related adverse events including endocrinopathies have been well described with programmed cell death 1 inhibitors such as pembrolizumab. While thyroid dysfunction is the most common endocrinopathy as...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Clara, Silva, Eugénia, Vieira, Ana Cláudia, Saraiva, Catarina, Duarte, Sequeira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Unusual Effects of Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859946/
https://www.ncbi.nlm.nih.gov/pubmed/35140188
http://dx.doi.org/10.1530/EDM-21-0123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859946/
https://www.ncbi.nlm.nih.gov/pubmed/35140188
http://dx.doi.org/10.1530/EDM-21-0123

Ejemplares similares